title: Yellow fever vaccine is safe and effective in HIV-infected patients.
authors.forename: Pierre
authors.initials: P
authors.lastname: Tattevin
authors.forename: Agnès Geremy
authors.initials: AG
authors.lastname: Depatureaux
authors.forename: Jean Marc
authors.initials: JM
authors.lastname: Chapplain
authors.forename: Mathieu
authors.initials: M
authors.lastname: Dupont
authors.forename: Faouzi
authors.initials: F
authors.lastname: Souala
authors.forename: Cédric
authors.initials: C
authors.lastname: Arvieux
authors.forename: Jean Dominique
authors.initials: JD
authors.lastname: Poveda
authors.forename: Christian
authors.initials: C
authors.lastname: Michelet
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D019562:Viral Load; D015004:Yellow Fever / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000008:administration & dosage*
chemical_list: D000914:Antibodies, Viral; D022341:Yellow Fever Vaccine